| Literature DB >> 35783509 |
Yue Li1, Meng-Yu Yan1, Qiao-Chu Chen1, Ya-Ya Xie1, Chen-Yu Li1, Feng-Juan Han2.
Abstract
Complementary and alternative medicine (CAM) encompasses a wide range of different non-mainstream therapies that have been increasingly used for the treatment or adjunct treatment of various ailments, with premature ovarian failure (POF) being one of the most common conditions treated with CAM. This review updates the progress of CAM in the treatment of POF, and we focus specifically on reviewing the evidence for the efficacy and mechanisms of a range of CAM treatments in POF, including single herbal medicines and their active ingredients, compound Chinese medicines, acupuncture and moxibustion, psychotherapy, exercise, vitamins, massage, and dietary supplements. According to the literature, CAM is very helpful for improving POF symptoms, and we hope to provide some instructive suggestions for clinical treatment and experimental research in the future. However, more clinical trials are needed to prove the safety of CAM.Entities:
Year: 2022 PMID: 35783509 PMCID: PMC9246583 DOI: 10.1155/2022/2574438
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.650
Figure 1Risk factors and etiology of POF.
Summary of the curative effects of single herbal medicines in POF.
| Single herbal medicine | Active ingredients | Outcomes | References |
|---|---|---|---|
| Epimedium | Icariin | FSH, LH↓; E2, AMH↑. | [ |
| Semen cuscutae | TFSC/cuscuta flavonoids | TFSC processing: E2↑. | [ |
| Pueraria lobata | Puerarin | FSH↓; E2, AMH↑; Bcl-2↑; Bax, cleaved caspase-3↓; | [ |
| Ginseng | Rg1 | FSH↓; E2, AMH↑; IL-1b, IL-6, TNF- | [ |
| American ginseng | / | FSH↓; E2↑; HPGDS, PLA2G4A, PTGS1↓; PAPPA, STC2, CCL2, NELL1↑. | [ |
| Cistanche | / | FSH↓; E2, AMH↑; IFN- | [ |
| Angelica | AP | SOD↑; MDA↓; IL-1 | [ |
| Lycium barbarum | LBP | FSH↓; E2↑; serum anti-zona pellucida antibody↓. | [ |
| Maca | / | FSH, LH↓; E2↑. | [ |
| Oyster | Oyster polypeptide | FSH↓; P↑; P53, Bad↓. | [ |
TFSC: total flavonoids from Semen cuscutae; AP: Angelica polysaccharide; LBP: Lycium barbarum polysaccharides. FSH: follicle-stimulating hormone; LH: luteinizing hormone; E2: estradiol; AMH: anti-Mullerian hormone; Bcl-2: B-cell lymphoma 2; Bax: Bcl-2-associated X protein; SOD2: superoxide dismutase 2; Nrf2: nuclear factor erythroid 2-related factor; IL-1b: interleukin-1b; IL-6: interleukin-6; TNF-α: tumor necrosis factor-alpha; LC3-II: light-chain 3 (LC3)-II; HPGDS: hematopoietic prostaglandin D synthase; PLA2G4A: phospholipase A2-IVA; PTGS1: prostaglandin-endoperoxide synthase 1; PAPPA: pregnancy-associated plasma protein A; STC2: stanniocalcin-2; CCL2 : C-C motif chemokine ligand 2; NELL1: NEL-like protein 1; IFN-γ: interferon-gamma; SOD: superoxide dismutase; MDA: malondialdehyde; IL-1β: interleukin-1beta.
Summary of the curative effects of TCM decoctions on POF.
| Chinese medicine decoction | Ingredients | Sample size | Interventions | Model used | Outcomes | References |
|---|---|---|---|---|---|---|
| Zuogui pill (ZGP) | Rehmanniae radix praeparata, cornel, yam, semen cuscutae, Chinese wolfberry fruit, radix achyranthis bidentatae, colla carapacis et plastri testudinis, and antler gelatin |
| Control group, model group, low-ZGP group, high-ZGP group, low-dose estradiol valerate, high-dose estradiol valerate, DAPT group, and DAPT + low-ZGP group | SD rats | FSH↓; E2, AMH↑; ovarian volume↑; ratio of total ovary weight to body weight↑. | [ |
|
| ||||||
| Bushen huoxue decoction (BHD) | Panax notoginseng powder, rhizoma cyperi, licorice, spatholobus suberectus stem, psoralea corylifolia, rhizoma curculiginis, semen cuscutae, cornel, angelica, epimedium, salvia miltiorrhiza, ligusticum wallichii, codonopsis pilosula, rehmanniae radix praeparata, and radix paeoniae alba. |
| BHD group and western medicine group (estradiol or estradiol didroxyprogesterone tablets) | Human study | FSH↓; AMH↑; TCM syndrome score↓; mir-23a, ovarian artery RI↓. | [ |
|
| ||||||
| Erxian decoction (EXD) | Rhizoma curculiginis, epimedium, morinda officinalis, anemarrhena, phellodendron amurense, and angelica. |
| Normal group, model group, bujiale group, low-EXD group, medium-EXD group, and high-EXD group | SD rats | FSH, LH↓; E2↑; TNF- | [ |
|
| ||||||
| Modified mulberry decoction (MMD) | Fructus mori, lilium brownii, angelica, rehmanniae radix praeparata, radix paeoniae alba, epimedium, cistanche, and licorice. |
| Control group: climen tablets treatment group: MMD | Human study | FSH, LH↓; E2↑; TCM syndrome score↓. | [ |
|
| ||||||
| Modified bazhen decoction (MBD) | Bupleurum, angelica, ligusticum wallichii, radix paeoniae alba, glutinous rehmannia, codonopsis pilosula, atractylodes, poria cocos, licorice, antlers, radix achyranthis bidentatae, and rhizoma cyperi |
| Control group, POF group, MBD group, and FES group | SD rats | XIAP↑; mir-23a, mir-27a↓. | [ |
|
| ||||||
| Danggui buxue decoction (DBD) | Angelica and astragalus mongholicus |
| Control group, model group, DBD group, quercetin group, and kaempferol group | SD rats | FSH, LH↓; E2, AMH↑; cytochrome c, Bax, p53 and IL6↓; ,ESR1, AR, Bcl-2↑. | [ |
|
| ||||||
| Si-Wu-Tang (SWT) | Rehmanniae radix praeparata, angelica, paeonia lactiflora pall, and ligusticum wallichii |
| Control group, model group, low-SWT group, medium-SWT group, high-SWT group, and DHEA group | Six C57BLmice | FSH, LH↓; E2, AMH↑; TCM syndrome score↓. | [ |
|
| ||||||
| Wenjing decoction (WJD) | Evodia rutaecarpa, cassia twig, radix paeoniae alba, angelica, ligusticum wallichii, donkey-hide gelatin, ophiopogon japonicus, ginger, rhizoma pinelliae, moutan bark, ginseng, and licorice |
| Control group: HRT (progynat + progesterone capsules) observation group: HRT (progynat + progesterone capsules), WJD, and acupuncture | Human study | FSH, LH↓; E2, AMH↑; TCM syndrome score↓. | [ |
DAPT: dual antiplatelet therapy; FES: Fufang Ejiao Syrup; DHEA: dehydroepiandrosterone; FSH: follicle-stimulating hormone; LH: luteinizing hormone; E2: estrogen; AMH: anti-Müllerian hormone; RI: resistance index; TNF-α: tumor necrosis factor-alpha; IFN-γ: interferon-gamma; VEGF: vascular endothelial growth factor; bFGF: basic fibroblastic growth factor; XIAP: X-linked inhibitor of apoptosis protein; IL6: interleukin-6; ESR1: estrogen receptor 1; AR: androgen receptor.
Summary of the efficacy of Chinese patent medicines on POF.
| Chinese patent medicine | Ingredients | Sample size | Interventions | Model used | Outcomes | References |
|---|---|---|---|---|---|---|
| Kuntai capsule (KTC) | Rehmanniae radix praeparata, rhizoma coptidis, donkey-hide gelatin, radix paeonia alba, poria cocos, and radix scutellariae. | / | / | / | FSH, LH↓; E2, AMH↑; Kupperman score↓. | [ |
|
| ||||||
| Kunbao pills (KBP) | Fructus ligustri lucidi, raspberry, semen cuscutae, Chinese wolfberry fruit, fleeceflower root, tortoise shell, Chinese wolfberry root bark, adenophora tetraphylla, ophiopogon japonicus, wild jujube kernel, glutinous rehmannia, radix paeoniae alba, radix paeoniae rubra, angelica, spatholobus suberectus stem, nacre mother of pearl, dendrobium nobile, chrysanthemum, eclipta, folium mori, radix cynanchi atrati, anemarrhena, and radix scutellariae. |
| Blank group, model group, low-KBP group, medium-KBP group, high-KBP group, and estrogen combination group | SD rats | FSH, LH↓; E2↑; TGF- | [ |
|
| ||||||
| Zishen yutai pill (ZYP) | Semen cuscutae, fructus amomi, rehmanniae radix praeparata, ginseng, parasitic loranthus, donkey-hide gelatin, fleeceflower root, folium artemisiae argyi, morinda officinalis, bighead atractylodes rhizome, codonopsis pilosula, cornu cervi degelatinatum, Chinese wolfberry fruit, teasel root, eucommia ulmoides |
| The control group (estradiol valerate tablets), the observation group (estradiol valerate tablets combined with ZYP) | Human study | FSH, LH↓; E2↑; Kupperman score↓. | [ |
|
| ||||||
| Fuke yangrong capsule (FYC) | Angelica, bighead atractylodes rhizome, rehmanniae radix praeparata, ligusticum wallichii, radix paeoniae alba, rhizome cyperi, motherwort, astragalus mongholicus, eucommia ulmoides, folium artemisiae argyi, ophiopogon japonicus, donkey-hide gelatin, licorice, dried tangerine peel, poria cocos, fructus amomi |
| The control group (sequential artificial cycle of estrogen and progesterone) and the observation group (sequential artificial cycle of estrogen and progesterone combined with FYC) | Human study | FSH, LH↓; E2↑; TCM syndrome score↓. | [ |
|
| ||||||
| Qilin pill (QLP) | Prepared fleeceflower root, eclipta, epimedium, semen cuscutae, cynomorium songaricum, codonopsis pilosula, radix curcumae, raspberry, Chinese wolfberry fruit, yam, red-rooted salvia root, astragalus mongholicus, radix paeoniae alba, pericarpium citri reticulatae viride, and fructus mori |
| Climen tablet group and climen tablets combined with QLP group | Human study | FSH, LH↓; E2↑. | [ |
|
| ||||||
| Bushen Tiaojing cream formula (BTCF) | Rehmanniae radix praeparata, yam, cornel, chinese wolfberry fruit, semen cuscutae, angelica, radix cyathulae, donkey-hide gelatin, motherwort, poria cocos, and moutan bark |
| The control group (HRT) and the observation group (HRT combined with BTCF) | Human study | FSH, LH↓; E2↑; GDF-9, BMP-15↑. | [ |
|
| ||||||
| Yunkang oral solution (YKos) | Yam, teasel root, astragalus mongholicus, angelica, rhizoma cibotii, semen cuscutae, parasitic loranthus, eucommia ulmoides, psoralea corylifolia, codonopsis pilosula, poria cocos, bighead atractylodes rhizome, donkey-hide gelatin, glutinous rehmannia, cornel, Chinese wolfberry fruit, smoked plum, radix paeoniae alba, fructus amomi, alpinia oxyphylla, radix boehmeriae, radix scutellariae, and folium artemisiae argyi |
| Control group, CTX model group, positive control group and high-YKos, medium-YKos and low-YKos groups | SD rats | FSH↓; E2↑; ovarian coefficient, uterine coefficient↑; GnRHR, FSHR↑. | [ |
CTX: cyclophosphamide; FSH: follicle-stimulating hormone; LH: luteinizing hormone; E2: estrogen; AMH: anti-Müllerian hormone; TGF-β1: transforming growth factor beta1; SCF: stem cell factor; GDF-9: growth differentiation factor 9; BMP15: bone morphogenetic protein 15; GnRHR: gonadotropin-releasing hormone receptor; FSHR: follicle-stimulating hormone receptor.
The frequency of use of Chinese herbal medicines for the treatment of POF.
| Drug efficacy | Number | Percentage (%) | Chinese herbal medicines and frequency |
|---|---|---|---|
| Tonic drug | 21 | 67.86 | Rehmanniae radix praeparata 164, angelica 164, semen cuscutae 163, yam 109, Chinese wolfberry fruit 106, radix paeoniae alba 76, licorice 67, fructus ligustri lucidi 66, epimedium 87, eucommia ulmoides 54, dried human placenta 46, morinda officinalis 43, bighead atractylodes rhizome 38, antler gelatin 38, radix glehniae 13, fructus mori 13, donkey hide gelatin 11, amethyst 10, ginseng 10, radix pseudostellariae 9, ophiopogon japonicus 9 |
| Drug for promoting blood circulation and removing stasis | 11 | 11.77 | Salvia miltiorrhiza 57, ligusticum wallichii 50, radix achyranthis bidentatae 28, radix cyathulae 24, safflower carthamus 24, spatholobus suberectus stem 23, motherwort 20, peach kernel 19, eupatorium 16, radix curcumae 10, motherwort fruit 10 |
| Astringent drug | 3 | 6.30 | Cornus officinalis 110, raspberry 24, schisandra chinensis 17 |
| Antipyretic drug | 5 | 5.09 | Moutan bark 39, phellodendron amurense 22, anemarrhena 21, rehmannia glutinosa 20, radix paeoniae rubra 20 |
| Diuretic and hygroscopic drug | 2 | 3.38 | Poria cocos 67, alisma orientalis 14 |
| Qi regulating drug | 2 | 2.84 | Rhizoma cyperi 48, dried tangerine peel 20 |
| Drug for treating external syndromes | 1 | 1.59 | Bupleurum 38 |
| Interior-warming drug | 2 | 1.17 | Cinnamomum cassia 17, radix aconiti carmichaeli 11 |
Modern acupuncture selection for the treatment of POF.
| Acupoint | International code | Meridians | Frequency of use | Percentage (%) |
|---|---|---|---|---|
| Guanyuan | RN4 | Ren | 34 | 73.91 |
| Shenshu | BL23 | Bladder | 29 | 63.04 |
| Sanyinjiao | SP6 | Spleen | 28 | 60.87 |
| Zhongji | RN3 | Ren | 21 | 45.65 |
| Zusanli | ST36 | Stomach | 19 | 41.30 |
| Zigong | EX-CA1 | Extra points | 18 | 39.13 |
| Pishu | BL20 | Bladder | 18 | 39.13 |
| Taixi | KI3 | Kidney | 17 | 36.96 |
| Taichong | LR3 | Liver | 16 | 34.78 |
| Ganshu | BL18 | Bladder | 16 | 34.78 |
| Xuehai | SP10 | Spleen | 15 | 32.61 |
| Qihai | RN6 | Ren | 14 | 30.43 |
| Guilai | ST29 | Stomach | 9 | 19.57 |
| Dahe | KI12 | Kidney | 7 | 15.22 |
| Ciliao | BL32 | Bladder | 7 | 15.22 |